Health Ministry to Add Sinovac-Pfizer Cross-Vaccine Option for Children Aged 12-17
A cross-vaccination approach using the Sinovac and Pfizer COVID-19 vaccines is now being developed as an option for recipients aged 12-17. The move comes in response to findings that this approach heightens immunity as effectively as two doses of only the Pfizer vaccine. The recommendation for cross-vaccination in teens was…